Pharmacological options in the treatment of benign prostatic hyperplasia

被引：162

作者：

Kenny, B ^{[1
]}

Ballard, S ^{[1
]}

Blagg, J ^{[1
]}

Fox, D ^{[1
]}

机构：

[1] PFIZER LTD,CENT RES,DEPT DISCOVERY CHEM,SANDWICH CT13 9NJ,KENT,ENGLAND

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1997年 / 40卷 / 09期

关键词：

D O I：

10.1021/jm960697s

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：1293 / 1315

页数：23

共 156 条

[31] ENDOCRINE PROPERTIES OF THE TESTOSTERONE 5-ALPHA-REDUCTASE INHIBITOR TUROSTERIDE (FCE-26073) [J].

DISALLE, E ;

BRIATICO, G ;

GIUDICI, D ;

ORNATI, G ;

PANZERI, A .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1994, 48 (2-3) :241-248

[32] 17-BETA-ACYLUREA DERIVATIVES OF 4-AZASTEROIDS AS INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE [J].

DISALLE, E ;

BRIATICO, G ;

GIUDICI, D ;

ORNATI, G ;

NESI, M ;

PANZERI, A .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 41 (3-8) :765-768

[33]

DIXON JS, 1996, TXB BENIGN PROSTATIC, P3

[34]

ELETREBY MF, 1991, J ANDROL, V12, P403

[35] A PROSPECTIVE, PLACEBO-CONTROLLED STUDY OF THE ANTIANDROGEN CASODEX AS TREATMENT FOR PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA [J].

ERI, LM ;

TVETER, KJ .

JOURNAL OF UROLOGY, 1993, 150 (01) :90-94

[36] A PROSPECTIVE, PLACEBO-CONTROLLED STUDY OF THE LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST LEUPROLIDE AS TREATMENT FOR PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA [J].

ERI, LM ;

TVETER, KJ .

JOURNAL OF UROLOGY, 1993, 150 (02) :359-364

[37] ALPHA-BLOCKADE IN THE TREATMENT OF SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA [J].

ERI, LM ;

TVETER, KJ .

JOURNAL OF UROLOGY, 1995, 154 (03) :923-934

[38] IDENTIFICATION OF ALPHA(1)-ADRENOCEPTOR SUBTYPES PRESENT IN THE HUMAN PROSTATE [J].

FAURE, C ;

PIMOULE, C ;

VALLANCIEN, G ;

LANGER, SZ ;

GRAHAM, D .

LIFE SCIENCES, 1994, 54 (21) :1595-1605

[39]

Ford APDW, 1996, MOL PHARMACOL, V49, P209

[40]

FORD APDW, 1995, BRIT J PHARMACOL, V114, pP24

← 1 2 3 4 5 6 7 8 9 10 →